34
Views
117
CrossRef citations to date
0
Altmetric
Article

Regulation of ABCG2 Expression at the 3′ Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line

, , &
Pages 5147-5161 | Received 27 Feb 2008, Accepted 11 Jun 2008, Published online: 27 Mar 2023

REFERENCES

  • Allikmets, R., L. M. Schriml, A. Hutchinson, V. Romano-Spica, and M. Dean. 1998. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58:5337–5339.
  • Ambros, V. 2004. The functions of animal microRNAs. Nature 431:350–355.
  • Bandres, E., E. Cubedo, X. Agirre, R. Malumbres, R. Zarate, N. Ramirez, A. Abajo, A. Navarro, I. Moreno, M. Monzo, and J. Garcia-Foncillas. 2006. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 5:29.
  • Basler, C. F., and M. S. Horwitz. 1996. Subgroup B adenovirus type 35 early region 3 mRNAs differ from those of the subgroup C adenoviruses. Virology 215:165–177.
  • Brennecke, J., A. Stark, R. B. Russell, and S. M. Cohen. 2005. Principles of microRNA-target recognition. PLoS Biol. 3:e85.
  • Chen, C., D. A. Ridzon, A. J. Broomer, Z. Zhou, D. H. Lee, J. T. Nguyen, M. Barbisin, N. L. Xu, V. R. Mahuvakar, M. R. Andersen, K. Q. Lao, K. J. Livak, and K. J. Guegler. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e179.
  • Chen, Y., and D. H. Gorski. 2008. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111:1217–1226.
  • Davis, S., B. Lollo, S. Freier, and C. Esau. 2006. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 34:2294–2304.
  • Didiano, D., and O. Hobert. 2006. Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat. Struct. Mol. Biol. 13:849–851.
  • Doench, J. G., and P. A. Sharp. 2004. Specificity of microRNA target selection in translation repression. Genes Dev. 18:504–511.
  • Donnini, M., A. Lapucci, L. Papucci, E. Witort, A. Jacquier, G. Brewer, A. Nicolin, S. Capaccioli, and N. Schiavone. 2004. Identification of TINO: a new evolutionarily conserved BCL-2 AU-rich element RNA-binding protein. J. Biol. Chem. 279:20154–20166.
  • Doyle, L. A., W. Yang, L. V. Abruzzo, T. Krogmann, Y. Gao, A. K. Rishi, and D. D. Ross. 1998. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 95:15665–15670.
  • Ebert, B., A. Seidel, and A. Lampen. 2005. Identification of BCRP as transporter of benz[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26:1754–1763.
  • Edwalds-Gilbert, G., K. L. Veraldi, and C. Milcarek. 1997. Alternative poly(A) site selection in complex transcription units: mean to an end? Nucleic Acids Res. 25:2547–2561.
  • Ee, P. L., S. Kamalakaran, D. Tonetti, X. He, D. D. Ross, and W. T. Beck. 2004. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 64:1247–1251.
  • Farh, K. K., A. Grimson, C. Jan, B. P. Lewis, W. K. Johnston, L. P. Lim, C. B. Burge, and D. P. Bartel. 2005. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 310:1817–1821.
  • Frohman, M. A. 1990. RACE: rapid amplification of cDNA ends, p. 28-38. In M. A. Inns, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, CA.
  • Graber, J. H., C. R. Cantor, S. C. Mohr, and T. F. Smith. 1999. In silico detection of control signals: mRNA 3′-end-processing sequences in diverse species. Proc. Natl. Acad. Sci. USA 96:14055–14060.
  • Griffiths-Jones, S. 2006. miRBase: the microRNA sequence database. Methods Mol. Biol. 342:129–138.
  • Grimson, A., K. K. Farh, W. K. Johnston, P. Garrett-Engele, L. P. Lim, and D. P. Bartel. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27:91–105.
  • He, L., and G. J. Hannon. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5:522–531.
  • Huff, L. M., J. S. Lee, R. W. Robey, and T. Fojo. 2006. Characterization of gene rearrangements leading to activation of MDR-1. J. Biol. Chem. 281:36501–36509.
  • Hutvagner, G., and P. D. Zamore. 2002. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297:2056–2060.
  • Jensen, L. E., and A. S. Whitehead. 2004. The 3′untranslated region of the membrane-bound IL-1R accessory protein mRNA confers tissue-specific destabilization. J. Immunol. 173:6248–6258.
  • Johnson, S. M., H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K. L. Reinert, D. Brown, and F. J. Slack. 2005. RAS is regulated by the let-7 microRNA family. Cell 120:635–647.
  • Knutsen, T., L. A. Mickley, T. Ried, E. D. Green, S. du Manoir, E. Schrock, M. Macville, Y. Ming, R. Robey, M. Polymeropoulous, R. Torres, and T. Fojo. 1998. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer 23:44–54.
  • Knutsen, T., V. K. Rao, T. Ried, L. Mickey, E. Schneider, K. Miyake, B. M. Ghadimi, H. Padilla-Nash, S. Pack, L. Greenberger, K. Cowan, M. Dean, T. Fojo, and S. Bates. 2000. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes Chromosomes Cancer 27:110–116.
  • Krishnamurthy, P., D. D. Ross, T. Nakanishi, K. Bailey-Dell, S. Zhou, K. E. Mercer, B. Sarkadi, B. P. Sorrentino, and J. D. Schuetz. 2004. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279:24218–24225.
  • Krutzfeldt, J., N. Rajewky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan, and M. Stoffel. 2005. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438:685–689.
  • Lander, E. S., L. M. Linton, B. Birren, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860–921.
  • Lee, N. S., T. Dihjima, G. Bauer, H. Li, M. J. Li, A. Ehsani, P. Salvaterra, and J. Rossi. 2002. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20:500–505.
  • Legendre, M., W. Ritchie, F. Lopez, and D. Gautheret. 2006. Differential repression of alternative transcripts: a screen for miRNA targets. PLoS Comput. Biol. 2:e43.
  • Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20.
  • Liao, R., J. Sun, L. Zhang, G. Lou, M. Chen, D. Zhou, Z. Chen, and S. Zhang. 2008. MicroRNAs play a role in the development of human hematopoietic stem cells. J. Cell Biochem. 104:805–817.
  • Maliepaard, M., M. A. van Gastelen, L. A. de Jang, D. Pluim, R. C. van Waardenburg, M. C. Ruevekamp-Helmers, B. G. Floot, and J. H. Schellens. 1999. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected tumor cell line. Cancer Res. 59:4559–4563.
  • Meister, G., M. Landthaler, Y. Dorsett, and T. Tuschi. 2004. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10:544–550.
  • Mickley, L. A., B. A. Spengler, T. A. Knutsen, J. L. Biedler, and T. Fojo. 1997. Gene rearrangement: a novel mechanism for MDR-1 gene activation. J. Clin. Investig. 99:1947–1957.
  • Miyake, K., L. Mickley, T. Litman, Z. Zhan, R. Robey, B. Cristensen, M. Brangi, L. Greenburger, M. Dean, T. Fojo, and S. E. Bates. 1999. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistance cells: demonstration of homology to ABC transport genes. Cancer Res. 59:8–13.
  • Nakanishi, T., K. J. Bailer-Dell, B. A. Hassel, K. Shiozawa, D. M. Sullivan, J. Turner, and D. D. Ross. 2006. Novel 5′ untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage. Cancer Res. 66:5007–5011.
  • Nishimori, T., H. Inoue, and Y. Hirata. 2004. Involvement of the 3′-untranslated region of cyclooxygenase-2 gene in its post-transcriptional regulation through the glucocorticoid receptor. Life Sci. 74:2505–2513.
  • Pesole, G., and S. Liuni. 1999. Internet resources for the functional analysis of 5′ and 3′ untranslated regions of eukaryotic mRNA. Trends Genet. 15:378.
  • Pillai, R. S. 2005. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11:1753–1761.
  • Rehmsmeier, M., P. Steffen, M. Hochsmann, and R. Giegerich. 2004. Fast and effective prediction of microRNA/target duplexes. RNA 10:1507–1517.
  • Robey, R., W. Y. Medina-Perez, K. Nishiyama, T. Lahusen, K. Miyake, T. Litman, A. M. Senderowicz, D. D. Ross, and S. E. Bates. 2001. Overexpression of the ATP-binding cassette half transporter, ABCG2 (Mxr/BCrp/ABCP1) in flavopiridol-resistant human breast cancer cells. Clin. Cancer Res. 7:145–152.
  • Roe, D. F., G. L. Craviso, and J. C. Waymire. 2004. Nicotinic stimulation modulates tyrosine hydroxylase mRNA half-life and protein binding to the 3′UTR in a manner that requires transcription. Brain Res. Mol. Brain Res. 120:91–102.
  • Saito, Y., G. Liang, G. Egger, J. M. Friedman, J. C. Chuang, G. A. Coetzee, and P. A. Jones. 2006. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 8:435–443.
  • Schiavone, N., P. Rosini, A. Quattrone, M. Donnini, A. Lapucci, L. Citti, A. Bevilacqua, A. Nicolin, and S. Capaccioli. 2000. A conserved AU-rich element in the 3′ untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J. 14:174–184.
  • Szatmari, I., G. Vamosi, P. Brazda, B. L. Balint, S. Benko, L. Szeles, V. Jeney, C. Ozvegy-Laczka, A. Szanto, E. Barta, J. Balla, B. Sarkadi, and L. Nagy. 2006. Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J. Biol. Chem. 281:23812–23823.
  • To, K. K. W., O. Polgar, L. Huff, M. Kuniaki, and S. E. Bates. 2008. Histone modifications at the ABCG2 promoter following treatment with HDAC inhibitor mirror those in multidrug-resistant cells. Mol. Cancer Res. 6:151–164.
  • To, K. K. W., Z. Zhan, and S. E. Bates. 2006. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol. Cell. Biol. 26:8572–8585.
  • Valencia-Sanchez, M. A., J. Liu, G. J. Hannon, and R. Parker. 2006. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20:515–524.
  • Volk, E. L., K. M. Farley, Y. Wu, F. Li, R. W. Robey, and E. Schneider. 2002. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res. 62:5035–5040.
  • Yekta, S., I. H. Shih, and D. P. Bartel. 2004. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304:594–596.
  • Yu, H., S. Stasinopoulos, P. Leedman, and R. L. Medcalf. 2003. Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin. J. Biol. Chem. 278:13912–13918.
  • Zhao, Y., E. Samal, and D. Srivastava. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214–220.
  • Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406–3415.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.